No definition available.
Iridocyclitis in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
H7_IRIDOCYCLITISINOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
585 |
4. Check minimum number of eventsNone |
585 |
5. Include endpointsNone |
585 |
6. Filter based on genotype QC (FinnGen only) |
558 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Iridocyclitis in diseases classified elsewhere based on the number of shared cases.
Similar with more cases:
- Iridocyclitis
- Disorders of sclera, cornea, iris and ciliary body
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 3920 | 2066 | 1843 |
Only index persons | 3697 | 1955 | 1742 |
Unadjusted period prevalence (%) | |||
Whole population | 0.06 | 0.06 | 0.05 |
Only index persons | 0.07 | 0.07 | 0.07 |
Median age at first event (years) | |||
Whole population | 53.62 | 55.44 | 51.59 |
Only index persons | 53.59 | 55.89 | 51.00 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 558 | 309 | 249 |
Unadjusted period prevalence (%) | 0.12 | 0.12 | 0.13 |
Median age at first event (years) | 54.03 | 52.05 | 56.48 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint H7_IRIDOCYCLITISINOTH and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
H7_IRIDOCYCLITISINOTH | 1.095 [0.91, 1.31] | 0.326 |
Birth year | 0.994 [0.99, 1.0] | 0.156 |
During the follow-up period (1.1.1998 — 31.12.2019), 252 out of 1718 females with H7_IRIDOCYCLITISINOTH died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
H7_IRIDOCYCLITISINOTH | 1.374 [1.14, 1.66] | 0.001 |
Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 266 out of 1621 males with H7_IRIDOCYCLITISINOTH died.
Mortality risk
Mortality risk for people of age
years, who have H7_IRIDOCYCLITISINOTH.N-year risk | Females | Males |
---|---|---|
1 | 0.099% | 0.265% |
5 | 0.543% | 1.506% |
10 | 1.49% | 3.577% |
15 | 2.793% | 6.832% |
20 | 5.292% | 11.356% |
Relationships between endpoints
↥Index endpoint: H7_IRIDOCYCLITISINOTH – Iridocyclitis in diseases classified elsewhere
GWS hits: -